Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Aranzazu Sancho-López"'
Autor:
Ignacio Darnaude-Ximénez, Antonio F Caballero-Bermejo, Belén Ruiz-Antorán, Myriam Aguilar-Pérez, Alicia Gómez-López, Aranzazu Sancho-López, Cristian García-Fadul, Elena Diago-Sempere, Manuel Valle Falcones, Piedad Ussetti-Gil, Cristina Avendaño-Solá
Publikováno v:
JMIR Research Protocols, Vol 11, Iss 9, p e37275 (2022)
BackgroundAspergillosis is the most frequently observed invasive fungal disease (IFD) in lung transplant recipients. Isavuconazole (ISA) has shown a better safety profile and noninferiority to voriconazole in the treatment of patients with IFD. Obje
Externí odkaz:
https://doaj.org/article/ad7b452043234a94aec8e2f59f0eb624
Autor:
Belén Ruiz-Antoran, Aranzazu Sancho-López, Rosario Cazorla-Calleja, Luis Fernando López-Pájaro, Ágata Leiva, Gema Iglesias-Escalera, Maria Esperanza Marín-Serrano, Marta Rincón-Ortega, Julián Lara-Herguedas, Teresa Rossignoli-Palomeque, Sara Valiente-Rodríguez, Javier González-Marques, Enriqueta Román-Riechmann, Cristina Avendaño-Solá
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 13, Iss 1, Pp 1-10 (2018)
Abstract Background Minocycline is an old tetracycline antibiotic that has shown antiinflammatory and antiapoptotic properties in different neurological disease mouse models. Previous single arm study in humans demonstrated benefits in individuals wi
Externí odkaz:
https://doaj.org/article/009879ee08ee409083a78b68dfda0da2
Autor:
Ignacio Darnaude-Ximénez, Antonio F Caballero-Bermejo, Belén Ruiz-Antorán, Myriam Aguilar-Pérez, Alicia Gómez-López, Aranzazu Sancho-López, Cristian García-Fadul, Elena Diago-Sempere, Manuel Valle-Falconés, Piedad Ussetti-Gil, Cristina Avendaño-Solá
BACKGROUND Aspergillosis is the most frequently observed invasive fungal disease (IFD) in lung transplant recipients. Isavuconazole has shown a better safety profile and non-inferiority to voriconazole in the treatment of patients with IFD. OBJECTIVE
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6fc90ca931664776200d5d95f815f293
https://doi.org/10.2196/preprints.37275
https://doi.org/10.2196/preprints.37275
Autor:
Pablo Rojo, Cinta Moraleda, Alfredo Tagarro, Sara Domínguez-Rodríguez, Lola Madrid Castillo, Luis Manuel Prieto Tato, Aranzazu Sancho López, Lilit Manukyan, Olivier Marcy, Valeriane Leroy, Alessandra Nardone, David Burger, Quique Bassat, Matthew Bates, Raoul Moh, Pui-Ying Iroh Tam, Tisungane Mvalo, Justina Magallhaes, W. Chris Buck, Jahit Sacarlal, Victor Musiime, Chishala Chabala, Hilda Angela Mujuru
Publikováno v:
Trials, vol 23, iss 1
Trials
Trials, 2022, 23 (1), pp.531. ⟨10.1186/s13063-022-06203-1⟩
Trials, 23, 531
Trials, 23, 1, pp. 531
Trials
Trials, 2022, 23 (1), pp.531. ⟨10.1186/s13063-022-06203-1⟩
Trials, 23, 531
Trials, 23, 1, pp. 531
Background Pneumonia is the primary cause of death among HIV-infected children in Africa, with mortality rates as high as 35–40% in infants hospitalized with severe pneumonia. Bacterial pathogens and Pneumocystis jirovecii are well known causes of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff859faa5677ed60e59e8d60e2aef572
https://doi.org/10.1186/s13063-022-06203-1
https://doi.org/10.1186/s13063-022-06203-1
Autor:
Antonio Gómez-Outes, Aránzazu Sancho-López, Antonio J. Carcas Sansuan, Cristina Avendaño-Solá
Publikováno v:
Pharmacological Research, Vol 199, Iss , Pp 107045- (2024)
Since the 1980s, medical specialists in Clinical Pharmacology have been playing a crucial role in the development of drug regulation in Spain. In this article we report on the activities carried out and the prospects for development in three very rel
Externí odkaz:
https://doaj.org/article/d0eb1a89545e4821b467ff6ca22fdfbd
Autor:
Ruiz-Antoran, Belén, Aranzazu Sancho-López, Cazorla-Calleja, Rosario, López-Pájaro, Luis, Ágata Leiva, Iglesias-Escalera, Gema, Marín-Serrano, Maria, Rincón-Ortega, Marta, Lara-Herguedas, Julián, Rossignoli-Palomeque, Teresa, Valiente-Rodríguez, Sara, González-Marques, Javier, Román-Riechmann, Enriqueta, Avendaño-Solá, Cristina
Figure S1. Analysis of responders at week 8, 16 and 24, defined as the proportion of patients with at least 1 month improvement in the age equivalents of the MP-R development index. Table S1. Absolute mean changes in specific domains of the MP-R scal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::71b181391f85a12d389ca14a60806f3f
Autor:
Elena Diago-Sempere, José Luis Bueno, Aránzazu Sancho-López, Elena Múñez Rubio, Ferrán Torres, Rosa Malo de Molina, Ana Fernández-Cruz, Isabel Salcedo de Diego, Ana Velasco-Iglesias, Concepción Payares-Herrera, Inmaculada Casas Flecha, Cristina Avendaño-Solà, Rafael Duarte Palomino, Antonio Ramos-Martínez, Belén Ruiz-Antorán
Publikováno v:
Trials, Vol 22, Iss 1, Pp 1-14 (2021)
Abstract Background COVID-19 is a respiratory disease caused by a novel coronavirus (SARS-CoV-2) and causes substantial morbidity and mortality. At the time this clinical trial was planned, there were no available vaccine or therapeutic agents with p
Externí odkaz:
https://doaj.org/article/6132297c8d1646ecbb0de369893edf99